<DOC>
	<DOCNO>NCT00235248</DOCNO>
	<brief_summary>The ARCH control trial sequential design prospective , randomize , open-label , blinded-endpoint ( PROBE ) methodology . The objective compare efficacy tolerance ( net benefit ) two antithrombotic strategy patient atherothrombosis aortic arch recent ( less 6 month ) cerebral peripheral embolic event . Hypothesis : The association clopidogrel 75 mg/d plus aspirin 75 mg/d 25 % effective oral anticoagulant ( target International Normalized Ratio [ INR ] 2 3 ) prevent brain infarction , brain hemorrhage , myocardial infarction , peripheral embolism , vascular death .</brief_summary>
	<brief_title>Aortic Arch Related Cerebral Hazard Trial ( ARCH )</brief_title>
	<detailed_description>Patients Transient Ischemic attack brain infarction unknown cause ( ipsilateral internal carotid artery origin stenosis great 70 % , ipsilateral severe intracranial stenosis artery supply infarcted area , definite cardiac source embolism ) precede 6 month atherosclerotic plaque . ≥ 4 mm aortic arch , patient peripheral event ( e.g . renal infarct ) precede 6 month plaque ≥ 4 mm thoracic aorta origin embolized artery .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Brain Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients sex age ≥ 18 year follow 4 inclusion criterion : One 3 follow ischemic event precede 6 month : Transient ischemic attack ( TIA ) Nondisabling brain infarct : Inclusion within 6 month onset Duration symptom sign great 24 hour Neurological sign time randomization Rankin Scale grade 3 less With normal compute tomography ( CT ) scan CT scan showing brain infarct ( even hemorrhagic infarct ) Peripheral embolism Atherosclerotic plaque thoracic aorta define wall thickness ≥ 4 mm protrude material large , measure transesophageal echocardiography multiplane transducer plaque le 4 mm mobile component . Informed consent sign Life expectancy &gt; 3 year Other cause embolism : Cardiac : endocarditis , atrial fibrillation , intracardiac thrombus , valvular prosthesis , rheumatic valvulopathy , leave ventricular aneurysm , ejection fraction le 25 % Atherosclerotic stenosis ipsilateral embolic territory : internal carotid artery stenosis great 70 % , severe ( judgment investigator ) intracranial stenosis , schedule carotid endarterectomy ( case inclusion possible 30 day procedure ) Uncommon cause : dissection , vasculitis , procoagulant state , sickle cell disease Other exclusion criterion : Intercurrent illness life expectancy le 36 month Pregnancy nonmenopausal woman Unwillingness participate Poor medication compliance expect Toxicomania Absolute indication anticoagulant therapy ( e.g . atrial fibrillation , intracardiac thrombus , prosthetic valve ) Scheduled carotid endarterectomy ( randomization possible 30 day endarterectomy ) CT scan intracranial lesion brain infarction ( space occupy mass , intracranial hemorrhage ) Transesophageal echocardiography ( TEE ) plaque ≥ 4 mm thickness distal suppose embolized artery ( judgement investigator ) . Contraindication clopidogrel , aspirin , oral anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>TIA/Brain infarct</keyword>
	<keyword>plaque &gt; 4mm aortic arch</keyword>
	<keyword>Or peripheral embolism</keyword>
	<keyword>plaque &gt; 4 mm thoracic aorta</keyword>
</DOC>